The Locator -- [(subject = "Trials--United States")]

312 records matched your query       


Record 41 | Previous Record | Long Display | Next Record
02859aam a2200421 a 4500
001 A26E0C966B5311E69AFE1DDBDAD10320
003 SILO
005 20160826010517
007 cr cn|||||||||
008 111204s2012    dcua     b    100 0 eng  
020    $a 0309219299
020    $a 9780309219297
035    $a (OCoLC)767570602
040    $a NLM $b eng $c NLM $d BTCTA $d UPM $d AAA $d NRZ $d YDXCP $d UKMGB $d IWA $d SILO
042    $a pcc
043    $a n-us---
050  4 $a R853 C55 P82 2011
111 2  $a Public Engagement and Clinical Trials: New Models and Disruptive Technologies $d (2011 : $c Mount Sinai School of Medicine)
245 10 $a Public engagement and clinical trials : $b new models and disruptive technologies : workshop summary / $c Victoria Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.
260    $a Washington, D.C. : $b National Academies Press, $c c2012.
300    $a xvi, 124 p. : $b 1 col. ill. ; $c 23 cm.
504    $a Includes bibliographical references (p. 85-87).
505 0  $a Introduction -- Recruitment challenges in clinical trials for different diseases and conditions -- Models for public engagement -- Messages and methods for public engagement -- The media -- Novel clinical trials designs -- The health system's structure and culture -- Toward a patient-centered strategy for clinical trials.
520    $a Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognition among many stakeholders that the U.S. clinical trials enterprise is unable to keep pace with the national demand for research results. The IOM, along with the Mount Sinai School of Medicine, held a workshop June 27-28, 2011, to engage stakeholders and experts in a discussion about possible solutions to improve public engagement in clinical trials.
530    $a Also issued online.
650  0 $a Clinical trials $z United States $v Congresses.
700 1  $a Weisfeld, Victoria D.
700 1  $a English, Rebecca A.
700 1  $a Claiborne, Anne B.
710 2  $a Institute of Medicine (U.S.). $b Forum on Drug Discovery, Development, and Translation.
710 2  $a Mount Sinai School of Medicine.
856 4  $u http://www.ncbi.nlm.nih.gov/books/NBK91498/
856 4  $u http://www.nap.edu/catalog.php?record%5Fid=13237
856 41 $3 National Academies Press $u http://www.nap.edu/catalog.php?record_id=13237
941    $a 1
952    $l USUX851 $d 20160826032404.0
956    $a http://locator.silo.lib.ia.us/search.cgi?index_0=id&term_0=A26E0C966B5311E69AFE1DDBDAD10320
994    $a C0 $b IWA

Initiate Another SILO Locator Search

This resource is supported by the Institute of Museum and Library Services under the provisions of the Library Services and Technology Act as administered by State Library of Iowa.